First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV
Clinical trial NCT04778904 · COMPLETED
Trial details
- NCT number
- NCT04778904
- Sponsor
- Barinthus Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2023-02-24
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.